GE HealthCare Technologies Inc. Common Stock Q3 2025 Earnings Recap

GEHC Q3 2025 October 30, 2025

Get alerts when GEHC reports next quarter

GE Healthcare demonstrated solid performance in Q3 2025 with a 4% organic revenue growth driven by robust customer demand and strategic investments, despite facing tariff pressures impacting margins.

Earnings Per Share Beat

$1.07 vs $1.05 est.

+1.9% surprise

Revenue Beat

5143000000 vs 5087127085 est.

+1.1% surprise

Market Reaction

1-Day -3.08%

5-Day -3.76%

30-Day -1.2%

See GEHC alongside your other holdings

Add to your portfolio — free

Key Takeaways

Organic revenue increased 4% year-over-year, supported by strong orders growth of 6% across all segments.
Adjusted EPS of $1.07 reflects a 6% decrease year-over-year, impacted by tariffs, though underlying performance would be higher without this effect.
Solid backlog of $21.2 billion underscores growth potential, aided by new multi-year enterprise deals and rising capital equipment demand.
Strategic investment in R&D and cost mitigation initiatives are expected to enhance margins and operational efficiency going forward.
Free cash flow reached $483 million, highlighting strong cash generation capabilities amidst ongoing investment and operational adjustments.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit GEHC on AllInvestView.

Previous Q2 2025

Next Q1 2026